Boston Scientific Corp/ US1011371077 /
| 2024-04-17 9:59:59 PM | Chg. -0.15 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 67.95USD | -0.22% | 245,207 Turnover: 16.63 mill. |
-Bid Size: - | -Ask Size: - | 99.7 bill.USD | - | 62.93 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,507 | 1,490 | 1,630 | 1,697 | 1,782 | ||||||
| Intangible Assets | 5,606 | 6,194 | 5,883 | 5,837 | 6,372 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 13,436 | 14,662 | 14,857 | 15,220 | 16,996 | ||||||
| Inventories | 946 | 1,016 | 955 | 1,078 | 1,166 | ||||||
| Accounts Receivable | 1,183 | 1,275 | 1,472 | 1,548 | 1,608 | ||||||
| Cash and Cash Equivalents | 587 | 319 | 196 | 188 | 146 | ||||||
| Current Assets | 3,606 | 3,471 | 3,239 | 3,822 | 4,003 | ||||||
| Total Assets | 17,042 | 18,133 | 18,096 | 19,042 | 20,999 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 262 | 209 | 447 | 530 | 349 | ||||||
| Long-term debt | 3,859 | 5,674 | 5,420 | 3,815 | 4,803 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1,214 | 735 | 18 | 191 | 328 | ||||||
| Liabilities | 10,585 | 11,813 | 11,363 | 12,030 | 12,273 | ||||||
| Share Capital | 16 | 16 | 16 | 16 | 16 | ||||||
| Total Equity | 6,457 | 6,320 | 6,733 | 7,012 | 8,726 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 17,042 | 18,133 | 18,096 | 19,042 | 20,999 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,380 | 7,477 | 8,386 | 9,048 | 9,823 | ||||||
| Depreciation (total) | 438 | 495 | 545 | 565 | 599 | ||||||
| Operating Result | -301 | -327 | 447 | 1,285 | 1,506 | ||||||
| Interest Income | -216 | -284 | -233 | -229 | -241 | ||||||
| Income Before Taxes | -509 | -650 | 177 | 933 | 1,422 | ||||||
| Income Taxes | -390 | -411 | -170 | 828 | -249 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -119 | -239 | 347 | 104 | 1,671 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,269 | 600 | 972 | 1,426 | 310 | ||||||
| Cash Flow from Investing Activities | -745 | -2,186 | -887 | -1,010 | -1,921 | ||||||
| Cash Flow from Financing | -150 | 1,322 | -206 | 110 | 1,432 | ||||||
| Decrease / Increase in Cash | 370 | -268 | -123 | 530 | -188 | ||||||
| Employees | 24,000 | 25,000 | 27,000 | 29,000 | 32,000 | ||||||
